IFP Advisors, Inc - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,662
-88.2%
366
-86.6%
0.00%
-100.0%
Q2 2023$48,043
+676.1%
2,722
+761.4%
0.00%
Q1 2023$6,190
+8742.9%
316
-90.9%
0.00%
-100.0%
Q4 2022$70
-99.9%
3,479
-20.2%
0.00%0.0%
Q3 2022$87,000
+13.0%
4,360
+13.5%
0.00%0.0%
Q2 2022$77,000
-9.4%
3,840
-9.8%
0.00%
+100.0%
Q1 2022$85,000
+1114.3%
4,258
+918.7%
0.00%
Q4 2021$7,000
-12.5%
4180.0%0.00%
Q3 2021$8,000
-65.2%
418
-68.3%
0.00%
Q2 2021$23,000
-8.0%
1,318
+4.9%
0.00%
Q1 2021$25,000
-30.6%
1,257
-34.1%
0.00%
-100.0%
Q4 2020$36,000
-16.3%
1,907
-21.8%
0.00%
-66.7%
Q3 2020$43,000
+34.4%
2,440
+40.8%
0.00%0.0%
Q2 2020$32,000
+6.7%
1,733
-13.3%
0.00%0.0%
Q1 2020$30,000
-36.2%
1,999
-14.5%
0.00%
-25.0%
Q4 2019$47,000
-4.1%
2,337
-18.0%
0.00%
+33.3%
Q3 2019$49,000
+4800.0%
2,850
+11300.0%
0.00%
Q1 2019$1,0000.0%250.0%0.00%
Q1 2016$1,000250.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders